Oramed Pharmaceuticals Inc. logo

ORMPOramed Pharmaceuticals Inc.

ORMP Stock Price, Valuation & Chart | Oramed Pharmaceuticals Inc.

Compare

ORMP Historical price chart

ORMP Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization207.50M
PE Ratio2.63
EPS1.93
Trading Volume188.60K
Today's High/Low5.14/4.96
Dividend Yield4.93
52 Week High/Low5.47/2.09
Shares Outstanding40.93M
ORMP Financial Statement
ORMP Analyst ratings
ORMP Analysis & performance metrics

ORMP Company profile

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or…

ORMP Management team

Management
Miriam Kidron Ph.D.CTO
Chief Scientific Officer & Director
Joshua HexterCOO
Chief Operating & Business Officer
Nadav Kidron Esq.CEO
President, Chief Executive Officer & Executive Chairman
Avraham GabayCFO
Chief Financial Officer, Treasurer & Secretary
Total 4 executives

ORMP Frequently asked questions

What is Oramed Pharmaceuticals Inc. (ORMP) Stock Price?

Current stock price of Oramed Pharmaceuticals Inc. (ORMP) stock is $5.070. The stock price is +4.54% higher in the session. The intraday range can be seen from this page. Volume of Oramed Pharmaceuticals Inc. (ORMP) stock is 188.60K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Oramed Pharmaceuticals Inc. (ORMP) stock price going up or down today?

The stock price of Oramed Pharmaceuticals Inc. (ORMP) can change with earnings, company news, and overall market sentiment. Oramed Pharmaceuticals Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Oramed Pharmaceuticals Inc. stock expensive at its current price?

Whether Oramed Pharmaceuticals Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ORMP on this page is 2.63. EPS on this page is 1.93. Compare those figures with peers and growth expectations before deciding if the current Oramed Pharmaceuticals Inc. price is justified.

How has the stock price of Oramed Pharmaceuticals Inc. (ORMP) performed historically?

Historical performance for Oramed Pharmaceuticals Inc. (ORMP) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ORMP reacted to past earnings and market events.

Should I buy Oramed Pharmaceuticals Inc. (ORMP) stock, at this price?

Buying Oramed Pharmaceuticals Inc. (ORMP) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.